The mechanistic contribution of cerebrovascular dysfunction to neurodegenerative diseases is difficult to determine. New single-cell transcriptomic analyses of human brain microvessels have identified transcriptomic signatures along the arteriovenous axis and transcriptional changes in the cerebrovasculature in Alzheimer disease and Huntington disease. This approach could advance our understanding of brain health and disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Toledo, J. B. et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre. Brain 136, 2697–2706 (2013).
Critchley, B. J., Isalan, M. & Mielcarek, M. Neuro-cardio mechanisms in Huntington’s disease and other neurodegenerative disorders. Front. Physiol. 9, 559 (2018).
Vanlandewijck, M. et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475–480 (2018).
Garcia, F. J. et al. Single-cell dissection of the human brain vasculature. Nature https://doi.org/10.1038/s41586-022-04521-7 (2022).
Yang, A. C. et al. A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk. Nature https://doi.org/10.1038/s41586-021-04369-3 (2022).
Dorrier, C. E., Jones, H. E., Pintarić, L., Siegenthaler, J. A. & Daneman, R. Emerging roles for CNS fibroblasts in health, injury and disease. Nat. Rev. Neurosci. 23, 23–34 (2022).
Yamamoto, Y. et al. Human iPS cell-derived mural cells as an in vitro model of hereditary cerebral small vessel disease. Mol. Brain 13, 38 (2020).
Kelleher, J. et al. Patient-specific iPSC model of a genetic vascular dementia syndrome reveals failure of mural cells to stabilize capillary structures. Stem Cell Reports 13, 817–831 (2019).
Kitaguchi, H., Ihara, M., Saiki, H., Takahashi, R. & Tomimoto, H. Capillary beds are decreased in Alzheimer’s disease, but not in Binswanger’s disease. Neurosci. Lett. 417, 128–131 (2007).
Sevigny, J. et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537, 50–56 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ihara, M., Yamamoto, Y. Transcriptomic mapping of the human cerebrovasculature. Nat Rev Neurol 18, 319–320 (2022). https://doi.org/10.1038/s41582-022-00650-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-022-00650-9
This article is cited by
-
Molecular biomarkers for vascular cognitive impairment and dementia
Nature Reviews Neurology (2023)